|
 |
SustivaThis page contains recent news articles, when available, and an overview of Sustiva but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Sustiva (when available) Efavirenz (dideoxyinosine, ddI) is an oral nucleoside reverse transcriptase inhibitor (NRTI). It is a synthetic purine derivative and, similar to zidovudine, zalcitabine, and stavudine. Efavirenz was originally approved specifically for the treatment of HIV infections in patients who failed therapy with zidovudine. Currently, the CDC recommends that Efavirenz be given as part of a three-drug regimen that includes another nucleoside reverse transcriptase inhibitor (e.g., lamivudine, stavudine, zidovudine) and a protease inhibitor or efavirenz when treating HIV infection. For use in combination treatment of HIV infection (AIDS) Mechanism Of Action: Similar to zidovudine, Efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of Efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of Efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated Efavirenz, this action may nevertheless account for some of the drug's toxicity. News Articles on Efavirenz Rilpivirine/Truvada Combo Pill Could Earn $2 Billion Yearly - Jan 4, 2010 Tibotec is hoping the Phase III studies prove the new drug is as effective as Sustiva (efavirenz)—but with fewer side effects—in first-time treatment takers ... AIDSmeds.com HIV/AIDS Treatment News Bristol-Myers spent $953K lobbying gov't in 3Q - Dec 23, 2009 The maker of Atripla and Sustiva for HIV infection lobbied for increased awareness and government funding to help pay for early treatment for people with ... The Associated Press Reyataz and Sustiva Co-Pay Programs Expanded - Dec 18, 2009 Both programs still cover up to $200 a month toward the total cost of co-payments for a regimen containing either Reyataz or Sustiva. ... AIDSmeds.com HIV/AIDS Treatment News FDA tentatively approves Matrix Labs' HIV treatment - Dec 22, 2009 ...it will be available in many developing countries. Bristol-Myers Squibb Co. markets efavirenz in the United States under the brand name Sustiva. Drug Store News (blog) TB, pregnancy, most common reasons for treatment changes in African study - Dec 10, 2009 The finding calls attention to the dilemma facing physicians who need to decide whether to prescribe nevirapine (Viramune) or efavirenz (Sustiva), ... Aidsmap Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015 ... - Dec 15, 2009 9.3.10 Sustiva Franchise 9.4 Competitive Profiling 9.4.1 Gilead 9.4.2 GlaxoSmithKline (GSK) 9.4.3 Bristol-Myers Squibb (BMS) 9.4.4 Abbott Laboratories ... IT News Online Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ... - Dec 10, 2009 Emtriva or Ziagen and Epivir along with either Norvir (ritonavir)-boosted Reyataz (atazanavir), a protease inhibitor, or Sustiva (efavirenz), an NNRTI. ... The AIDS Beacon (blog) Most NNRTI-experienced patients in southern Africa will benefit from etravirine - Dec 17, 2009 Research in the UK suggests that nearly all patients with resistance to the older NNRTIs efavirenz (Sustiva, also in the combination pill Atripla) or ... Aidsmap In-depth analysis of unmet needs, drivers and barriers that impact global HIV ... - Dec 10, 2009 This is primarily due to the patent expiry of major drugs such as Sustiva and Combivir in 2012. However the impact of patent expiration will be offset by ... News-Medical.net 2010ë…„ 8ê°œ 블ë¡?버스터 ì‹ ì•½ 출시 - Dec 29, 2009 J&Jì?˜ '릴피비린'ì?€ 차세대 NNRTI HIV ì¹˜ë£Œì œë¡œ NNRTI ì €í• ê· ì£¼ì—?ë?„ 효과ì ?ì?´ë©° ìž„ìƒ?ì—?ì„œ '서스티바'(Sustiva, efavirenz)보다ë?„ 우월한 효과와 ì•ˆì „ì„±ì?„ 보였다. ... 디지틀보사 Vlaamse aidsremmers voeren wereldranglijst aan - Dec 10, 2009 Atripla is een zogenaamde triple pil , waarbij Truvada wordt gecombineerd met de virusremmer Sustiva van Bristol Myers-Squibb. Door die driedubbele werking ... Trends Gilead shares fall despite surge in 3Q profit - Oct 21, 2009 ...( BMY - news - people )'s Sustiva. Sales of Gilead's HIV treatment Truvada rose 13 percent to $620.6 million, while sales of Viread rose 9 percent to $169.7 ... Forbes FDA Safety Changes: Ultram, Ultracet, Sustiva, Kayexalate - Oct 28, 2009 On September 23, the FDA approved safety labeling revisions for efavirenz capsules and tablets (Sustiva; Bristol-Myers Squibb Co) to warn of drug ... Medscape Bristol-Myers posts higher 3Q sales, lower profit - Oct 22, 2009 ...also boosted the performance for the maker of Abilify, which treats schizophrenia and bipolar disorder, and HIV drugs Sustiva and Reyataz. ... The Associated Press No Heart Rhythm Problem With 25 mg of Rilpivirine - Nov 5, 2009 To explore this further, Simon Vanveggel, PhD, and his colleagues at Tibotec in Antwerp, Belgium, compared rilpivirine with Sustiva (efavirenz) and a ... AIDSmeds.com HIV/AIDS Treatment News B-MS posts strong sales for most of its drugs - Oct 23, 2009 As for the firm's HIV drugs, sales of the Sustiva (efavirenz) franchise rose 7% to $315 million, and Reyataz (atazanavir) was up 5% to $360 million. ... Pharma Times Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter - Oct 22, 2009 The virology portfolio continues to demonstrate worldwide sales growth, led by BARACLUDE for hepatitis B (+33%), the Sustiva franchise (+7%) and REYATAZ for ... Reuters Nitrogen Atom-Directed Ortho-Lithiation Aids Preparation of Anti-HIV Drug - Nov 10, 2009 ...it to synthesize a non-nucleoside reverse transcriptase inhibitor (NNRTI) called efavirenz, the active ingredient in the anti-HIV-1 drug, Sustiva. ... AZoNano.com Earnings for Two - Oct 22, 2009 Results were driven by Plavix (up 8%) and Abilify (up 16%), Baraclude (up 33%), Sustiva (up 7%), Reyataz (up 5%), Orencia (up 36%) and Sprycell (up 30%). ... TheStreet.com (subscription) Quarterly - PRESS RELEASE: BB BIOTECH: Positive performance in the third quarter - Oct 29, 2009 We believe this has the potential to replace Sustiva, the NNRTI component of Atripla. A successful launch could solidify Gilead's leading position in HIV ... Ad-Hoc-News (Pressemitteilung) å‡ æ”¯è‚¡å†?ä¸?买就晚了! - Oct 28, 2009 ...ä¸ç§‘å?ˆè‡£ï¼ˆ600490）公å?¸ä¸»è¦?产å“?02A是一ç§?环丙基乙炔化å?ˆç‰©ï¼Œè¯¥äº§å“?是生产特效抗艾滋病è?¯ç‰©Sustivaçš„é‡?è¦?ä¸é—´ä½“ï¼Œå› è€Œå?ˆå…·å¤‡æŠ—艾滋病功能。公å?¸å‡å€Ÿè‡ªèº«çš„高科技优势， ... 证券之星 Intelence® (étravirine) : de rares cas de réactions cutanées sévères - Nov 3, 2009 Dans cette famille, la névirapine (Viramune®) et l'efavirenz (Sustiva®) sont déjà connus pour entraîner des réactions cutanées sévères chez de rares ... ARCAT å?‰åˆ©å¾·ç§‘å¦ä¸‰å£åº¦åˆ©æ¶¦ä¸Šæ¶¨è‚¡ç¥¨ä¸‹è·Œ 艾滋病è?¯ - Oct 21, 2009 N）Sustiva的结å?ˆäº§ç‰©ã€‚ 专利费ã€?å?ˆå?Œè´¹å¹¶å…¶ä»–的收入近五å€?至1.524äº¿ç¾Žå…ƒã€‚å› ç”²æµ?的大规模æµ?行使达è?²é”€å”®é‡?大增，使其罗æ°?销售达è?²çš„专利费æˆ?为其é‡?è¦?收入æ?¥æº?。 ... 生物谷 BB BIOTECH: Positive Performance im dritten Quartal 2009 - Oct 28, 2009 TMC278 hat das Potenzial, Sustiva als sogenannten NNRTI-Bestandteil von Atripla zu ersetzen. Durch eine erfolgreiche Vermarktung des neuen ... PR-Inside.com (Pressemitteilung) Gilead regista subida de 36% nos lucros - Oct 22, 2009 As vendas do Atripla®, que associam o Truvada com o Sustiva®, da Bristol-Myers Squibb num único comprimido, aumentaram 42%, para 605,3 milhões, ... RCM Pharma FDA Clears Once-a-Day AIDS Drug - Jul 13, 2006 ...s Sustiva and Gilead's Truvada, which is itself a two-drug combination. ... FDA approved Sustiva in 1998 and the two Gilead drugs -- Viread and Emtriva ... Washington Post Gilead's Truvada-Sustiva Issues Are A 'Minor Setback' - Aug 10, 2005 Standard & Poor's Equity Research reiterated a "strong buy" rating on Gilead Sciences (nasdaq: GILD - news - people ) and the research firm remains positive ... Forbes New HIV Regimen Outperforms Gold Standard - Jan 18, 2006 In the first year of a three-year randomized trial, it proved significantly more effective and less toxic than a regimen consisting of Sustiva plus AZT and ... CNN Sustiva 30 Caps X 200 Mg - Oct 20, 2007 ...set by the United States, the Sustiva 30 Caps X 200 Mg body that regulates pharmaceuticals is the EMEA and they enforce standards set by the European ... Sokwanele New Medicine for AIDS Is One Pill, Once a Day - Jul 9, 2006 The new drug is a combination of drugs already on the market — Sustiva, ... Doctors and securities analysts expect most people now taking Sustiva and ... New York Times Gilead HIV Pill Fails - Apr 26, 2005 After markets had closed, Gilead said it would reformulate the pill, which combines its Truvada HIV pill with Bristol-Myers Squibb's Sustiva HIV medication. ... TheStreet.com - TheStreet.com (subscription) Bloomberg Printer-Friendly Page - Oct 26, 2008 Selzentry failed to equal Sustiva in a test last year, in part because of inaccuracies in the test that indicates who should be helped by it. ... Bloomberg Studies: Newer HIV drugs more tolerable for many - Oct 27, 2008 ...s widely used Sustiva, with both groups also taking a widely used combination ... Meanwhile, 44 percent getting Isentress and 77 percent taking Sustiva had ... eTaiwan News Gilead HIV drug shows promise New regimen posts promising results in ... - Jan 19, 2006 The third ingredient in the one-a-day pill is Sustiva, made by Gilead's partner ... In the comparison group taking Combivir plus Sustiva, 73 percent reached ... San Francisco Chronicle Discount Sustiva COD - May 12, 2007 ...of Medicine at East Carolina University - Pharmaceutical Sciences Program * Discount Sustiva COD Discount Sustiva COD of the body on the legal jurisdiction. ... Sokwanele Ardea HIV drug meeting study goals - Mar 17, 2008 That study would also focus on safety and effectiveness and would compare the experimental drug with Bristol-Myers Squibb Co.'s Sustiva. ... Boston Globe Gilead, Merck Sign Atripla Pact - Aug 11, 2006 In those places, it's sold by Bristol-Myers Squibb (BMY) as Sustiva. ... The drug combines Sustiva, or now Stocrin, and Gilead's Truvada. ... TheStreet.com - TheStreet.com (subscription) More Lipoatrophy with Sustiva vs. Kaletra - Feb 26, 2007 By Tim Horn. Additional results from a study comparing three HIV drug regimens indicates that Kaletra® (lopinavir/ritonavir) combined with two nucleoside ... AIDSmeds.com HIV/AIDS Treatment News Sustiva.(drug overview)(Drug overview) - Dec 1, 2005 Sustiva is one of the growing number of drugs used to fight HIV infection. HIV, the human immunodeficiency virus, weakens the immune system until it can no ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Once-a-day HIV drug cocktail — in one pill — wins FDA approval - Jul 16, 2006 The drugs are Bristol-Myers Squib's Sustiva and Gilead Pharmaceutical's Truvada, a combo of Viread and Emtriva. Taking the trio as a single pill makes it ... USA Today Sustiva Edges Out Celsentri in Treatment Newbies - Jul 25, 2007 By Tim Horn. A clinical trial has found that Pfizer's CCR5-blocking entry inhibitor, Celsentri (maraviroc), when used by patients starting HIV treatment for ... AIDSmeds.com HIV/AIDS Treatment News Sustiva Use During Pregnancy May Cause Fetal Harm - Jun 14, 2005 June 14, 2005 — The US Food and Drug Administration (FDA) and Bristol-Myers Squibb have warned healthcare professionals via letter against the use of ... Medscape Potential Drug Interaction Between Sustiva and Dilantin - Jan 4, 2008 The anticonvulsant Dilantin (phenytoin) can drastically reduce levels of the HIV drug efavirenz—found in Sustiva/Stocrin and Atripla—in the blood when both ... AIDSmeds.com HIV/AIDS Treatment News Gilead's Debt Sale Seen Fueling Potential Deals - Apr 27, 2006 ..."We continue to anticipate significant market share gains for Gilead following the introduction of a single pill Truvada/Sustiva combination in the second ... Forbes Sustiva from Canadian Pharmacy - Jun 17, 2007 ...alter the Sustiva properties. This means when a useful activity has been identified, chemists will make many similar compounds called analogues, ... Sokwanele IAC: Sustiva vs. Kaletra – ACTG Study Declares a Likely Winner - Aug 18, 2006 By Tim Horn, Senior Writer & Editor, AIDSmeds.com. The US Department of Health and Human Services (DHHS) currently recommends either Sustiva® (efavirenz) or ... AIDSmeds.com HIV/AIDS Treatment News Tentative USFDA nod for Aurobindo's 3rd AIDS drug - Jun 26, 2005 Food and Drug Administration (USFDA) for another anti-AIDS drug Efavirenz, the generic version of Sustiva tablets, manufactured by Bristol-Myers Squibb. ... Hindu Business Line Merck's Isentress Comparable to Sustiva as a First-Time Treatment - Jul 24, 2007 By Tim Horn. Results from an ongoing clinical trial of Isentress (raltegravir), Merck's experimental integrase inhibitor, suggest that it has comparable ... AIDSmeds.com HIV/AIDS Treatment News No Prescription Sustiva - Sep 2, 2007 ...(eg half-life and volume of distribution), and pharmacodynamics describes the effect of No Prescription Sustiva Sciences in Philadelphia - Pharmacology ... Sokwanele HIV/AIDS – the withdrawal of 100mg Sustiva angers patients' associatio... - Mar 28, 2008 ...“A clear step backwards in the paediatric treatment of HIVâ€?. The TRT-5 group of associations against HIV/AIDS has condemned the halting “without prior ... دستناسيون سنتي - دستناسيون سنتي Gilead Set For Further Upside On Strong HIV Franchise - Apr 19, 2006 The analyst is bullish on the prospects for Gilead's triple combo HIV pill, which combines Viread and Emtriva with Bristol-Myers Squibb's Sustiva. ... Forbes Purchase Sustiva Without Prescription - Nov 10, 2007 ...the drug Purchase Sustiva Without Prescription Purchase Sustiva Without Prescription therapeutic effect or desired outcome.[1] The safety and effectiveness ... Sokwanele Gilead: Truvada, Sustiva combo creates daily HIV regimen. - Jan 9, 2006 SAN FRANCISCO (MarketWatch) -- Gilead Sciences said Monday it has succesfully co-formulated its HIV drug, Truvada, with Bristol-Myers Squibb's Sustiva to ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … : combination of Viread, Videx, and either Sustiva or Viramune.(may... - Apr 1, 2005 The combination of Viread, Videx, and either Sustiva or Viramune may cause early virologic failure in patients taking HIV needs for the first time. ... $4.95 - HIV Treatment: ALERTS! - ECNext Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine … - Oct 17, 2007 Through 48 weeks, 84 percent of patients in the Viread/Emtriva/SUSTIVA group (n=244) compared to 73 percent of patients in the Combivir/SUSTIVA group ... Free with registration - PR Newswire - AccessMyLibrary.com IAC: Efavirenz (Sustiva) the Pick in Severely Immunocompromised … - Aug 5, 2008 By Michael Smith, North American Correspondent, MedPage Today. MEXICO CITY, Aug. 5 -- In HIV patients who begin treatment with a damaged immune system, ... MedPage Today 96-Week Data From Gilead's Study 934 Comparing Viread(R) and … - Dec 15, 2006 ..."Sustiva, Emtriva and Viread were administered as individual agents in this trial, ... Viread, Emtriva and Sustiva are available in the United States as ... RedOrbit Sustiva warnings.(FDA Bits)(Food and drug administration)(drug … - Apr 1, 2005 Sustiva warnings.(FDA Bits)(Food and drug administration)(drug interaction alert)(Brief Article) ... find HIV Treatment: ALERTS! articles. Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research Sustiva Buy - Sep 7, 2007 ...reach the open market, this is an expensive way of doing Sustiva Buy costing millions of Dollars. To recoup this outlay pharmaceutical companies may do a ... Sokwanele LDL Drops with Sustiva to Viramune Switch - Jun 12, 2007 ...by Kenyon Farrow. HIV-positive people taking Sustiva® (efavirenz) may be able to lower their levels of bad cholesterol by switching to Viramune® ... AIDSmeds.com HIV/AIDS Treatment News Gilead announces preliminary 48-week data from study 934 comparing … - Feb 3, 2005 This study was designed to compare a regimen of Viread (tenofovir disoproxil fumarate), Emtriva (emtricitabine) and Bristol-Myers Squibb's Sustiva ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com IAC: Sustiva vs. Kaletra? We Have a Likely Winner - Aug 21, 2006 ...by Tim Horn. The US Department of Health and Human Services (DHHS) currently recommends either Sustiva® (efavirenz) or Kaletra® (lopinavir plus ritonavir) ... AIDSmeds.com HIV/AIDS Treatment News Pfizer HIV Drug Shows Promise - Oct 29, 2008 The re-analysis showed that 68 percent of patients in the Selzentry arm and 68 percent of patients in the Sustiva arm had undetectable levels of the virus, ... FDA news - FDA news (subscription) Strides Arcolab gets USFDA nod for anti-HIV drug - Mar 28, 2007 Efavirenz, is the generic version of Bristol Myers Squibb's 'Sustiva', which helps in preventing the HIV virus from reproduction. ... Hindu Sustiva warnings.(FDA Bits)(Food and drug administration)(drug … - Apr 1, 2005 New precautions have been added to the labeling for Sustiva regarding interactions with Vfend (voriconazole), a drug used to treat serious fungal infections ... $4.95 - HIV Treatment: ALERTS! - ECNext California and the West; IN BRIEF / BIOTECHNOLOGY; Gilead Says HIV … - Jan 10, 2006 Researchers showed that a single pill combining Gilead's Viread and Emtriva medicines and Bristol-Myers' Sustiva was equivalent to taking the three drugs ... Pay-Per-View - Los Angeles Times - ProQuest Archiver BMS' HIV DRUG SUSTIVA MAY CAUSE FETAL HARM, FDA SAYS - Jun 21, 2005 Bristol-Myers Squibb's (BMS) HIV-1 treatment Sustiva could cause fetal harm when administered during a pregnant patient's first trimester, according to an ... Pay-Per-View - FDAnews Drug Daily Bulletin - Factiva, from Dow Jones Sustiva drug interactions.(FDA BITS) | Article from HIV Treatment: … - Jun 1, 2007 Sustiva drug interactions.(FDA BITS) ... find HIV Treatment: ALERTS! articles. In January, new precautions were added to the labeling for the "non-nuke" ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research Unprecedented work key to new HIV pill / Two drug companies … - Jul 20, 2006 Atripla combines the active ingredients in three HIV drugs - Sustiva, ... Some Web sites list Sustiva as costing about $500 a month for 30 600-milligram ... Pay-Per-View - Richmond Times - Dispatch - ProQuest Archiver FDA Safety Labeling Changes: Plavix, Sustiva, Prevpac - Jul 13, 2005 July 13, 2005 — The US Food and Drug Administration (FDA) approved in April revisions to safety labeling to advise that use of clopidogrel bisulfate has ... Medscape Rilpivirine (TMC-278) Has Metabolic Edge Over Sustiva - Jul 24, 2007 By Tim Horn. Additional side-effect data from a clinical trial of rilpivirine (TMC-278), Tibotec's experimental non-nucleoside reverse transcriptase ... AIDSmeds.com HIV/AIDS Treatment News New Merck HIV treatment 'comparable' to Sustiva - Aug 14, 2006 An ongoing trial of MK-0518, an investigational HIV treatment, found it had a similar effect on HIV RNA as market-leader Sustiva, according to its ... Hays Pharma Truvada combo a no go? - Aug 22, 2005 ...s Sustiva (efavirenz). The companies plan to use a bi-layer technology to develop up ... This was compared to the recommended 600 mg dose of Sustiva alone. ... ICIS Aurobindo surges on FDA approval - Dec 23, 2006 Efavirenz is the generic version of Bristol Myers Squibb's brand drug Sustiva. Earlier, on Thursday, the company along with two other Indian firms Ranbaxy ... Business Standard Bristol-Myers Squibb and Gilead Sciences Submit New Drug Application ... - Apr 27, 2006 Sustiva, Truvada, Viread and Emtriva will continue to be sold by the respective ... SUSTIVA is a prescription medicine used in combination with other ... RedOrbit Merck & Co: new HIV drug compares well with Sustiva - Oct 2, 2006 The lower lipid levels and equal efficacy compared with Sustiva may potentially place MK-0518, Merck & Co's novel integrase inhibitor, in the first-line of ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Article: Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency... - Feb 15, 2006 Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency virus)(Brief Article) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research … Comparing Truvada(R) to Combivir(R) Both in Combination With Sustiv... - Jul 23, 2007 At study initiation, patients received Viread and Emtriva with Sustiva. ... Truvada and Sustiva are also available in the United States as the fixed-dose ... RedOrbit Sustiva-Viread-Emtriva combo for HIV.(Human immunodeficiency virus)( … - Feb 15, 2006 Combination therapy with Sustiva, Viread, and Emtriva was superior to combined Sustiva and Combivir for treating HIV in treatment-naive patients enrolled in ... Free with registration - Internal Medicine News - AccessMyLibrary.com Gilead Study Confirms Atripla Efficacy - Jul 24, 2007 At study initiation, patients received Viread and Emtriva with Sustiva. ... Truvada and Sustiva are also available in the US as the fixed-dose product ... RedOrbit Non-Nuke TMC-278 Comparable to Sustiva - Mar 2, 2007 By Tim Horn. An international team of researchers presented the first results from a Phase II study of rilpivirine (TMC-278), Tibotec's experimental ... AIDSmeds.com HIV/AIDS Treatment News … - 72 FR 5060 Determination That SUSTIVA (Efavirenz) 300-Milligram ... - Feb 2, 2007 SUSTIVA (efavirenz) is approved for the treatment of human immunodeficiency ... SUSTIVA (efavirenz) 300-mg tablets are the subject of NDA 21-360 held by ... Pay-Per-View - Federal Register 2007 - Loislaw … a day.(New treatment combination)(Sustiva)(Truvada)(Emtriva)(Viread... - Apr 1, 2005 New treatment combination)(Sustiva)(Truvada)(Emtriva)(Viread)(Brief Article) ... find HIV Treatment: ALERTS! articles. The simpler the HIV treatment regimen ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research 96-Week Data from Gilead's Study 934 Comparing Viread(R) and Emtriva … - Aug 14, 2006 Viread, Emtriva and Sustiva are available in the United States as the fixed-dose product ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir ... Free with registration - Business Wire - AccessMyLibrary.com Truvada/Sustiva cuts viral load vs Combivir/Sustiva. - Aug 6, 2007 Truvada/Sustiva cuts viral load vs Combivir/Sustiva. USA-based Gilead Sciences presented strong 144-week data from an ongoing clinical trial comparing a ... $9.94 - Pharma Marketletter - Alacra Store Sustiva drug interactions.(FDA BITS) - Jun 1, 2007 In January, new precautions were added to the labeling for the. $4.95 - HIV Treatment: ALERTS! - ECNext Poor Adherence May Explain Worse Sustiva Responses Among Blacks - Oct 24, 2007 Poorer adherence may explain why black patients are less likely to achieve or maintain undetectable viral loads using a Sustiva (efavirenz)-based treatment ... AIDSmeds.com HIV/AIDS Treatment News Sustiva: revised drug-interaction information. - Nov 1, 2006 On January 31 the FDA announced that the Sustiva (efavirenz) package insert had been changed "to include drug-drug interaction information regarding ... Free with registration - AIDS Treatment News - AccessMyLibrary.com … : combination of Viread, Videx, and either Sustiva or Viramune.(may... - Apr 1, 2005 Caution: combination of Viread, Videx, and either Sustiva or Viramune.(may cause early virologic failure)(Advertisement) ... find HIV Treatment: ALERTS! Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research "Stocks on the Rise". - Jan 19, 2006 Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of ... with Sustiva once daily in treatment-naive patients with HIV. ... Free with registration - M2 Presswire - AccessMyLibrary.com abc13.com: Health news from KTRK about you and your family 7/31/06 - Jul 31, 2006 Sustiva is made by New York-based Bristol-Myers Squibb Co. The pill will be just as expensive as Truvada and Sustiva when purchased separately: The ... go.com Gilead's Atripla, Lower Costs Provide Lift To First Quarter - Apr 23, 2007 ...s HIV compound Sustiva (efavirenz). Atripla sales added up to $190.2 million, a sequential increase of 38 percent from $137.4 million in the fourth quarter ... BioWorld Online - BioWorld Online Netherlands Corporate News - Amerikaanse Food and Drug … - Dec 7, 2006 This difference largely results from the higher number of discontinuations in the Combivir/SUSTIVA group due to adverse events (9% vs. ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Children's Sustiva Dose May Need to be Upped - Jul 5, 2007 In developing countries where therapeutic drug level monitoring is not readily available, HIV-infected children taking efavirenz are likely to be ... AIDSmeds.com HIV/AIDS Treatment News European CHMP Issues Positive Opinion For ATRIPLA(R) (efavirenz 600 … - Oct 19, 2007 Efavirenz is marketed by Bristol-Myers Squibb under the tradename SUSTIVA(R) in the United States, Canada and six European countries (France, Germany, ... Medical News Today - Medical News Today (press release) Netherlands Corporate News - Bristol-Myers Squibb en Gilead meldt … - Sep 1, 2006 SUSTIVA does not cure HIV or help prevent passing HIV to others. SUSTIVA should not be taken with Hismanal(R) (astemizole), Propulsid(R) (cisapride), ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Antivirals: meeting a world of need: the fight against AIDS requires... - Oct 1, 2005 Last December, for example, Gilead Sciences and BMS announced plans to develop an FDC combining Gilead's Truvada (emtricitabine/tenofovir) and BMS' Sustiva ... Free with registration - Pharmaceutical Executive - AccessMyLibrary.com European Commission Approves ATRIPLA(R), the First Once-Daily … - Dec 17, 2007 Efavirenz is marketed by Bristol-Myers Squibb Company (NYSE: BMY) under the tradename SUSTIVA(R) in the United States, Canada and six European countries ... Lifescience-online BMS and Gilead Agree to Commercialize Atripla in Canada - Sep 29, 2006 Atripla combines Bristol's Sustiva® (efavirenz) and Gilead's Truvada® (emtricitabine and tenofovir disoproxil fumarate), itself a fixed-dose reformulation ... Genetic Engineering News - Genetic Engineering News (press release) Gilead Sciences at Banc of America Securities 2006 Health Care … - May 18, 2006 It's a combination of our double drug Truvada along with BMS's Sustiva. We'll talk a little bit more about that in a moment. That's under review at the FDA. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Gilead Sciences at Goldman Sachs Annual Global Healthcare … - Jun 14, 2006 We're calling the single tablet regimen, so this is a combination product of Truvada, which contains two products already, and Sustiva, also known as ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … a day.(New treatment combination)(Sustiva)(Truvada)(Emtriva)(Viread... - Apr 1, 2005 In December, Bristol-Myers Squibb and Gilead Sciences announced that they will work together to develop a fixed-dose combination of Sustiva, ... $4.95 - HIV Treatment: ALERTS! - ECNext Product news from the 04/28/06 News Brief - Apr 28, 2006 ...new drug application to the FDA for approval of a product combining the anti-HIV medications Sustiva (efavirenz), manufactured by Bristol-Myers Squibb, ... Medical Marketing & Media - Medical Marketing and Media FDA approves single HIV antiretroviral pill.(NATION IN BRIEF)(Food... - Sep 1, 2006 Atripla, the first one-pill product to treat HIV/AIDS, combines the active ingredients of Sustiva, Emtriva and Viread. Bristol-Myers Squibb and Gilead ... Free with registration - Nation's Health - AccessMyLibrary.com Easier To Use AIDS Regimen Less Effective - Oct 13, 2005 Services is urging newly diagnosed patients to forgo therapies that specifically combine Videx and Viread with so-called "non-nuke" drugs like Sustiva. ... Health Video Side-effects major reason UK patients switch from first-line therapy,... - Oct 21, 2005 A total of 41 patients switched due to central nervous system -related side-effects; 40 (98%) were on efavirenz (Sustiva) prior to switching. ... Aidsmap Once-a-day HIV pill.(CLINICAL CAPSULES)(Brief Article) - Feb 1, 2005 ...including Bristol-Myers Squibb's drug Sustiva (efavirenz), and Gilead's drug Truvada, which combines Emtriva (emtricitabine) and Viread (tenofovir ... Free with registration - Internal Medicine News - AccessMyLibrary.com Update on the CNS Adverse Effects of Sustiva® (Efavirenz) - Oct 1, 2006 By Kiron Punwani, Shannon Suedkamp, Diem Nguyen, and Jessica C. Song, Kiron Punwani, Shannon Suedkamp, and Diem Nguyen are PharmD Candidates at the ... Pay-Per-View - Infectious Disease Alert - Factiva, from Dow Jones ä¸ç§‘å?ˆè‡£(600490)：在涨å?œé™„è¿‘æ?¢æ‰‹å·¨å¤§ - Jan 24, 2008 ...å…¬å?¸ä¸»è¦?产å“?02A是一ç§?生产特效艾滋病è?¯ç‰©SUSTIVAçš„é‡?è¦?ä¸é—´ä½“，公å?¸å¹´äº§20å?¨æŠ—艾滋病 è?¯ä¸é—´ä½“项目目å‰?处于生产调试和工艺优化阶段，ä¸?久将投放市场。 ... 腾讯网 HIV/AIDS Treatment; Drug makers putting complete AIDS treatment in... - Jan 14, 2005 The combination pill will be made up of Sustiva, made by Bristol-Myers Squibb, ... Sustiva is from a different class of drugs and attacks the virus later in ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Patent challenges: drug makers want Thai officials to uphold intellect... - Jun 1, 2007 The Thai government has issued compulsory licenses to make or buy generic equivalents of Merck's Sustiva (efavirenz) and Abbott's Kaletra (lopinavir/ ... $9.94 - Pharmaceutical Executive - Alacra Store [强势点评]ä¸ç§‘å?ˆè‡£:é“¶æ ¹æ”¾æ?¾ç»?è?¥æ”¹å–„ - Nov 5, 2008 1ã€?抗艾题æ??：公å?¸ä¸»è¦?产å“?02A是一ç§?环丙基乙炔化å?ˆç‰©ï¼Œè¯¥äº§å“?是生产特效抗艾滋病 è?¯ç‰©Sustivaçš„é‡?è¦?ä¸é—´ä½“ï¼›245化å¦å??称为å?«æ°Ÿè‹¯ç”²é…¸ï¼Œæ˜¯ç”Ÿäº§ä¸€ç±»æ–°åž‹æŠ—è?Œ ... 网易 efavirenz + emtricitabine + tenofovir disoproxil Bristol-Myers Squibb... - May 8, 2006 ...reverse transcriptase inhibitor efavirenz (SUSTIVA) (600 mg), and Gilead Sciences' TRUVADA, which comprises the nucleoside reverse transcriptase inhibitors ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones SP discontinues vicriviroc trial on efficacy issues.(Schering-Plough... - Nov 7, 2005 ...spring of 2004 in 23 centers across Europe and Canada and compared the vicriviroc regimen with Combivir plus Bristol-Myers Squibb's Sustiva (efavirenz). ... $4.95 - Pharma Marketletter - ECNext Hypertension risks.(12th Retrovirus Conference HIGHLIGHTS)( … - Apr 1, 2005 Another study also found this relationship, in particular with the use of non-nucleoside reverse transcriptase inhibitors ("non-nukes") such as Sustiva or ... $4.95 - HIV Treatment: ALERTS! - ECNext FDA Approves REYATAZо (atazanavir Sulfate) 300 Mg Single Capsule … - Oct 23, 2006 Indication:SUSTIVA is a prescription medicine used in combination with other medicines ... SUSTIVA does not cure HIV or help prevent passing HIV to others. ... Medical News Today - Medical News Today (press release) Bristol-Myers Squibb Extends Assistance to State AIDS Drug Assistance... - Mar 22, 2005 SUSTIVA is a prescription medicine used in combination with other medicines to treat ... SUSTIVA does not cure HIV or help prevent passing HIV to others. ... Free with registration - PR Newswire - AccessMyLibrary.com Les enfants privés de Sustiva® - May 31, 2008 Nous en avions fait une brève dans le dernier Protocoles, nous y revenons aujourd'hui vu l'inertie de Bristol Myer Squibb sur ce sujet. ... Act Up-Paris IAC: Data, Access for Integrase Inhibitor - Aug 17, 2006 In the Sustiva group, approximately 92% of patients experienced viral load reductions to less ... In the Sustiva group, CD4 counts increased by 112 cells. ... AIDSmeds.com HIV/AIDS Treatment News HIV patients get first once-a-day pill - Aug 9, 2006 Sustiva is made by New York-based Bristol-Myers Squibb Co. ... Nor will the new pill be suitable for all patients: Sustiva, for instance, can cause birth ... msnbc.com J&J HIV drug matches Bristol-Myers drug in trial - Feb 28, 2007 N) Sustiva in previously untreated patients, researchers said on Wednesday. TMC278 is designed to block an enzyme the HIV virus needs to replicate. ... Reuters abc30.com: Health Watch - Best HIV Combo 12/24/06 - Dec 24, 2006 Results show the combination that included Sustiva suppressed the virus to ... A third regimen, however, showed when Sustiva was used with Kaletra alone ... go.com Taking a Break? (HIV Treatment Interruptions) - Jun 29, 2006 For example, if someone stops their Sustiva and two nucleoside analogues on the ... This would be like taking only the Sustiva without the addition of other ... AIDSmeds.com HIV/AIDS Treatment News 艾滋病控制新è?¯å°†ä¸Šå¸‚æ¯?æ—¥å?ªéœ€æœ?用1片 - Jul 12, 2006 ...å?³å°†æŽ¨å‡ºçš„æ¯?æ—¥1片的新è?¯ç”±ç™¾æ—¶ç¾Ž-施贵å®?å…¬å?¸ç”Ÿäº§çš„è?¯ç‰©Sustivaå’Œå?‰é‡Œå¾·ç§‘å¦å…¬å?¸ç”Ÿäº§ çš„è?¯ç‰©Truvada组å?ˆ ... æ— è®ºæ˜¯Sustiva还是Truvada，它们都是已在广泛使用的è?¯ç‰©ã€‚ ... 人民网 Studies Disagree on Abacavir for Patients With High Viral Loads - Aug 12, 2008 One group started a regimen containing Epzicom and Sustiva (efavirenz), another started a regimen containing Epzicom and Norvir (ritonavir)-boosted Reyataz ... AIDSmeds.com HIV/AIDS Treatment News Brand Names/Synonyms: Sustiva is also known by the following brand names and/or synonymsDMP 266; DMP-266; EFV; Efavirenz; Stocrin; Sustiva Drug Category: Sustiva is categorized under the following by the FDA: Anti-HIV Agents; Nonnucleoside Reverse Transcriptase Inhibitors; ATC:J05AG03 Dosage Forms: TABLET, CAPSULE Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 8-chloro-5-(2-cyclopropylethynyl)-5-(trifluoromethyl)-4-oxa-2-azabicyclo[4.4.0]deca-7,9,11-trien-3-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
